Back to search
Gastro-Intestinal Tolerance
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Gastro-Intestinal Tolerance trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Gastro-Intestinal Tolerance trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The ADICROHN-3 study is a prospective, multicenter, open-label cohort study. Its design is supported by the following elements: * The results of the ADICROHN…
This study will evaluate the recommended dose for further clinical development, safety, tolerability, anti-tumor activity, immunogenicity, pharmacokinetics and…
Patients with pancreatic cancer (pancreatic ductal adenocarcinoma (PDAC) and pancreatic neuroendocrine tumor (NET)) commonly experience fat malabsorption due to…
The aim of the study is to assess the effectiveness of this new formula on regurgitations and secondarily its effect on digestive tolerance through a randomized…
Study Objective This clinical trial primarily aims to investigate whether semi-elemental enteral nutrition (SEN) improves gastrointestinal tolerance in patients…
This is a multi-center, prospective, non-randomized, non-blinded, single-arm, single treatment study.
Introduction: Refeeding syndrome (RS) is a life-threatening metabolic complication of nutritional support. Prolonged fasting, frequently observed in malnourishe…
The purpose of this study is to determine the optimal dose of soluble fibers that induces tolerable gastrointestinal symptoms.